A recent meta-analysis further demonstrated increased NfL concentrations in serum and plasma among patients with Alzheimer’s disease (AD) and frontotemporal dementia (FTD), when compared to individuals without cognitive impairments (Gu et al., 2023). Here, NEFL is linked to Cognitive impairment.